When a child has a debilitating and fatal disease, a desperate parent might try anything, including risky experimental ...
In the preceding three months, 19 analysts have released ratings for Vertex Pharmaceuticals VRTX, presenting a wide array of ...
Five U.S. consumer groups and two large labor unions urged the U.S. Federal Trade Commission on Thursday to block Novo ...
Intellia Therapeutics' innovative gene editing technology could revolutionize medicine, but investors need a strong stomach ...
Multiple sclerosis (MS) is a chronic disease in which the myelin sheath, an insulation that surrounds nerve cells, is slowly destroyed. | Genetics And Genomics ...
BMO Capital analyst Kostas Biliouris maintained a Buy rating on Intellia Therapeutics (NTLA – Research Report) today and set a price ...
A collaborative effort between investigators at the National Institutes of Health’s National Institute of Allergy and Infectious Diseases (NIAID) and Massachusetts General Hospital (MGH), a founding ...
A collaborative effort between investigators at the National Institutes of Health's National Institute of Allergy and ...
Because sickle cell disease isn’t as progressive a disease as others that have gene therapies available, there isn’t as much ...
The Tasmanian tiger, a wolf-like marsupial that once stalked the forests of Tasmania, could be brought back from extinction ...
The results provide the first clinical evidence of RNA editing, a burgeoning field that's drawn interest from biotechs and pharmaceutical companies alike.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback